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ABSTRACT 
Host factors regulating retroviral replication  
by interactions with viral RNA and DNA 
 
Gary Zhe Wang 
 
Retroviruses are capable of infecting diverse vertebrates, and successful infection requires 
intimate interaction between virus and the host cell. During an infection, retroviral particles must 
bind specifically to cell surface receptors on the target cell, cross the plasma membrane, reverse-
transcribe their RNA genome into double stranded DNA, find their way to the nucleus, enter the 
nucleus and integrate its DNA into host chromosomes. Following integration, expression of viral 
mRNA ensues, followed by viral mRNA export into the cytoplasm, translation of viral mRNA 
into proteins, and assembly of new virions that will egress from the host cell. We now appreciate 
that at many steps of this complex process, the virus must hijack the cellular machinery to 
replicate. At the same time, the host cell mobilizes a variety of cellular defense mechanisms to 
suppress viral infection. This thesis investigates various aspects of virus-host interactions. I will 
first describe the involvement of cellular transcriptional repressor protein ErbB3 binding protein 
1 (EBP1) in facilitating transcriptional shutdown of Moloney murine leukemia virus (MLV) gene 
expression in mouse embryonic cells. Next, I describe a novel means of regulating the activity of 
Yin Yang 1 (YY1), a cellular transcription factor regulating retroviral gene expression, through 
post-translational modifications. I show that YY1 is a target of tyrosine phosphorylation by Src 
family kinases. Phosphorylation of YY1 impairs its ability to bind DNA and RNA, thereby 
downregulating its activity as a transcription factor on retroviral and cellular promoters. Apart 
from studying retroviral gene expression, I have also investigated intrinsic cellular defenses 
against retroviral infection. This is exemplified by our finding that mouse cells are intrinsically 
resistant to infection by betaretroviruses such as Mason-Pfizer monkey virus (M-PMV). The 
block against M-PMV occurs after reverse transcription and prior to viral nuclear entry. Finally, I 
will present ongoing work examining the fate of viral DNAs following infection, focusing on the 
kinetics of its association with cellular core histones and viral structural proteins. Together, this 
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CHAPTER 1 - INTRODUCTION 
Overview of the retroviral life cycle 
Retroviruses are single-stranded positive-sense RNA viruses capable of infecting many 
vertebrates. Infection typically results in life-long chronic viremia. The key to their persistence is 
the integration of proviral DNA into the genome of the host’s somatic and germ-line cells. 
Infection can cause cell death and lead to depletion of the target cell population; or more often 
can eventually lead to leukemia by insertional mutagenesis. 
A retroviral virion contains two copies of the single-stranded RNA genome, which 
encodes the viral proteins required for productive infection. All known retroviruses contain three 
major genes called “gag’, “pol”, and “env’, which encode structural proteins (gag), enzymes 
such as reverse transcriptase and protease (pol), as well as surface and transmembrane proteins 
(env) (Fig. 1-1). The viral genes in the context of the integrated viral DNA are flanked on either 
end by repeated nucleic acid sequences termed long terminal repeats (LTR). LTRs play 
indispensable roles in the retroviral life cycle, including viral integration into the host genome 
and regulation of viral gene expression. 
The life cycle of retroviruses can be divided into two phases (Fig. 1-2). The early phase 
begins with binding of virions to cell surface receptors and ends with integration of viral DNA 
into the host chromosomes. The late phase begins with the expression of viral genes and ends 
with the maturation and release of new virions from the cell surface.  
In the first step of the retroviral life cycle, viral envelope glycoproteins interact with 
cognate cellular surface receptors. For example, ecotropic Moloney murine leukemia virus 
(MLV) utilizes a ubiquitously expressed mouse amino acid transporter (mCAT) to gain entry 





Figure 1-1: The genome architecture of retroviruses 
The representative genome of Moloney murine leukemia virus (MLV) is shown. Viral genes, 
gag, pol, and env are flanked on both ends by LTR sequences.  




Figure 1-2: The retroviral life cycle 
Retroviral life cycle can be divided into two phases. Early phase begins with virion binding to 
cell surface receptors and ends with integration. Late phase begins with transcription of viral 




virus-1 (HIV-1)  utilizes the CD4 protein of T-lymphocytes as the receptor (Maddon et al, 1986). 
The presence or absence of a particular cell surface receptor defines the virus’s cell-type tropism. 
Receptor attachment is followed by entry of the virus into the host cell. Different viral envelopes 
mediate virus entry into the target cell via distinct mechanisms (Fig. 1-3). For example, the 
glycoprotein from vesicular stomatitis virus (VSV-G) promotes viral entry via endocytosis, while 
amphotropic (ampho) MLV envelope and HIV-1 envelope facilitate direct fusion with the 
plasma membrane (McClure et al, 1990). In the case of ecotropic (eco) MLV envelope, there 
exists evidence consistent with both endocytosis (i.e. pH dependence) and direct cell fusion (i.e. 
pH independence) (Mothes et al, 2000; Nussbaum et al, 1993). 
Following cell entry, the viral core, containing the RNA genome and its associated 
proteins, is released into the cytoplasm of the target cell and undergoes partial uncoating to give 
rise to a ribonucleoprotein complex termed the reverse transcription complex (RTC). With the 
help of the viral-encoded reverse transcriptase enzyme, the single-stranded viral RNA genome is 
converted into double-stranded viral DNA genome in a stepwise manner (Fig. 1-4). First, cellular 
tRNA bound to the primer binding site (PBS) of the viral genomic RNA functions to prime DNA 
synthesis by reverse transcriptase. This is followed by strand extension and strand transfer 
reactions, leading to the generation of full length viral DNA genomes. What triggers the 
initiation of reverse transcription is not completely understood. One possibility is that exposure 
of RTC to the presence of deoxyribonucleotides in the cytoplasm of the host cell may be 
sufficient to drive reverse transcription (Goff, 2001). 
Following reverse transcription, viral DNA genomes undergo trafficking toward the 
nucleus of the infected cell. Given that the cellular cytoplasm is densely populated with proteins 





Figure 1-3: Modes of viral entry into the host cell 
Different viral envelopes enter the cell by distinct mechanisms. The glycoprotein of vesicular 
stomatitis virus (VSV-G) enters the cell by first binding to cell surface receptors. Endocytosis 
and subsequent exposure of the virus to the low endosomal pH triggers the fusion of the viral 
membrane with the endosomal membrane, this is termed pH-dependent entry. In contrast, the 
envelope protein of amphotropic MLV, or HIV-1 can bind to cell surface receptors and directly 






Figure 1-4: Retroviral reverse transcription reaction 
1. Using host tRNA as a primer, minus-strand DNA synthesis proceeds until the 5’ end of the 
genomic RNA is reached. This short DNA intermediate is termed minus-strand strong-stop DNA 
(sss-DNA).  
2. RNase-H degrades the RNA strand of the RNA-sssDNA duplex. sssDNA undergoes strand 
transfer and anneals to the 3’ end of the viral genomic RNA. 
3. Minus-strand DNA synthesis resumes, while RNase H digestion of the RNA template strand 
occurs. Note that all of the RNA template is degraded by RNase H with the exception of a 
short stretch of RNA called polypurine tract (PPT). 
4. The remaining PPT portion of the viral RNA genome serves to prime plus-strand DNA 
synthesis. 
5. RNase H removes the primer tRNA, and sssDNA anneals to the complementary PBS 
segment in minus-strand DNA, this process is called second strand transfer. 
6. Plus and minus-strand synthesis is complete.  




of reaching the target. Consequently, retroviruses have evolved means to hijack cellular 
cytoskeletal machinery to facilitate purposeful movements toward the cell nucleus. For 
example, HIV-1 infection induces the formation of stable microtubules in the infected cell, 
which functions as specialized tracks for HIV-1 particle transport toward the nucleus (Sabo et 
al, 2013). 
 The nuclear envelope of infected cells poses a formidable barrier to retroviral nuclear 
translocation (Fig. 1-5). Indeed, retroviruses such as MLV are unable to penetrate intact nuclei of 
infected cells, and must therefore depend on breakdown of the nuclear envelope during mitosis 
to gain nuclear entry (Roe et al, 1993). In contrast, lentiviruses such as HIV-1 are able to actively 
transverse the nuclear envelope of non-dividing cells such as resting T-lymphocytes and 
macrophages (Weinberg et al, 1991). Here, certain HIV-1 proteins interact with 
nucleocytoplasmic shuttling receptors called importins to gain nuclear entry in a manner similar 
to cellular proteins.  
Once inside the nucleus, the viral encoded integrase enzyme catalyzes the insertion of 
linear viral DNAs into the host chromosomes (Fig. 1-6). The integration reaction proceeds in two 
steps. First, integrase catalyzes the removal of two nucleotides from the 3’ terminus of the viral 
LTR, termed 3’-end processing (Brown et al, 1989; Roth et al, 1989). The resultant viral DNA 
substrate is then joined to the target DNA on host chromosomes through a strand transfer 
reaction (Craigie et al, 1990; Engelman et al, 1991). Structurally, the catalytic pocket of integrase 
from many different retroviruses contain a centrally located D-D(35)-E motif. For MLV, 
mutations in the D-D(35)-E motif (e.g. D184A) results in the loss of all catalytic activity, making 






Figure 1-5: Modes of viral nuclear entry 
Different viruses enter the nucleus of the infected cell by different mechanisms. To gain access 
to host chromosomes, MLV requires the dissolution of nuclear envelope during cell division. In 
contrast, HIV-1 can be actively imported into the nucleus by interaction with nuclear pore 



















Figure 1-6: Viral integration reaction 
The integration reaction proceeds in two distinct steps. First, integrase catalyzes the removal of 
two nucleotides from the 3’ terminus of the viral LTR, termed 3’-end processing. This exposes a 
3’ hydroxyl group (OH), which acts as a nucleophile to attack target DNA during the joining 
reaction. Joining reaction generates a DNA gap with 5’ 2-nucleotide overhangs, which can then 
be removed, and the gap repaired to complete integration. 





Do retroviruses integrate randomly or at preferred sites in the host genome? Initial in 
vitro studies demonstrated that proviral insertion occurs irrespective of DNA sequences but is 
influenced by the chromatin structure (Pryciak et al, 1992). Gammaretroviruses such as MLV 
prefers to integrate near transcription start sites, as well as in the vicinity of strong enhancers and 
active promoters (De Ravin et al, 2014; LaFave et al, 2014; Wu et al, 2003). Lentiviruses 
including HIV-1 prefer to integrate inside the bodies of active genes, especially genes that were 
activated in cells following HIV-1 infection (Schroder et al, 2002). Thus, such strong bias in 
integration site selection may promote robust retroviral gene expression.  
Following integration, the viral promoter encoded in the LTR region functions to drive 
the transcription of viral genes in a manner similar to cellular genes. The resultant viral RNA can 
then be exported into the cytoplasm and be translated by host ribosomes to generate viral 
proteins. Alternatively, full length viral RNA can also be packaged directly into progeny virions. 
After assembly of viral RNA and proteins, new immature virions bud from the plasma 
membrane and the Gag and Gag-Pol precursor proteins undergo proteolytic cleavage by the viral 






Transcriptional regulation of MLV in embryonic cells 
MLV is unable to replicate in mouse embryonic stem (ES) or embryonic carcinoma (EC) 
cells (Barklis et al, 1986; Teich et al, 1977). In embryonic cells, reverse transcription and 
proviral integration proceed normally, but viral transcription is repressed, and hence no viral 
gene products can be detected. Several mechanisms are likely involved in the transcriptional 
silencing, including 1) the absence of enhancer proteins recognizing binding sites in the viral 
LTR (Hilberg et al, 1987; Linney et al, 1984); 2) recruitment of trans-acting transcriptional 
repressors (Akgun et al, 1991; Flanagan et al, 1989; Tsukiyama et al, 1989), and 3) de novo 
DNA methylation (Niwa et al, 1983). One critical site for transcriptional silencing, termed the 
repressor binding site (RBS), shows extensive overlap (17/18 bps) with the primer binding site 
(PBSpro) of MLV (Barklis et al, 1986; Feuer et al, 1989; Loh et al, 1987), which normally 
functions during the priming of reverse transcription by host proline tRNA. The RBS by itself is 
sufficient to induce potent transcriptional repression of reporter constructs in EC cells, 
irrespective of its orientation or position (Loh et al, 1990; Petersen et al, 1991). In addition, 
electrophoretic mobility shift assays (EMSAs) using RBS as the probe demonstrate the presence 
of stem-cell specific nuclear factors. A single base-pair mutation in the RBS, termed the B2 
mutation, is sufficient to abolish nuclear factor binding, and thereby restore viral gene expression 
(Loh et al, 1990; Petersen et al, 1991). These findings have allowed the characterization of the 
stem-cell specific trans-acting transcriptional repressor complex as containing Trim28 (also 
known as KAP-1 or Tif1-beta), a known transcriptional co-repressor (Wolf et al, 2008a; Wolf & 
Goff, 2007; Wolf et al, 2008b), and Krüppel associated box (KRAB) zinc finger protein 809 
(ZFP809) (Wolf & Goff, 2009), a DNA binding transcription factor. The current model for PBS-
mediated silencing consists of the binding of PBSpro by ZFP809, and the subsequent recruitment 




dependent recruitment of additional chromatin modifiers such as the histone H3K9 
methyltransferase SETDB1 (Schultz et al, 2002), heterochromatin-associated protein gamma 
(HP1gamma) (Wolf et al, 2008a), the NURD histone deacetylases complex (Schultz et al, 2001) 
and EBP1 (Wang et al, 2014). Together, the ensuing histone and DNA methylation of the 
proviral DNA ensures transcriptional silencing and genomic stability (Fig. 1-7). 
Beside the ZFP809/Trim28 complex, another zinc finger protein, Yin Yang 1 (YY1), also 
binds to the LTR of MLV in embryonic cells, augmenting the recruitment of Trim28 and 
downstream chromatin modifiers to the proviral DNA (Schlesinger et al, 2013). YY1 binding to 
the viral LTR occurs rapidly following infection, leading to the initiation of MLV promoter 
silencing. Indeed, retroviral gene expression is significantly upregulated upon MLV infection of 
embryonic cells devoid of YY1, or by infecting wild-type embryonic cells with MLV LTR 
mutant that no longer bind YY1. Therefore, both ZFP809 and YY1 are capable of binding 
separate DNA sequences on the viral LTR and act to cooperatively recruit Trim28 and its 






Figure 1-7: Mechanism of MLV silencing in mouse embryonic cells 
(A) In embryonic cells, two zinc finger transcription factors, YY1 and ZFP809 binds to unique 
DNA sequences in the MLV LTR upon infection. Together, this leads to the recruitment of 
Trim28, a host transcriptional repressor, as well as chromatin modifiers such as histone 
methyltransferase SETDB1, NuRD histone deacetylases complex, HP1 and EBP1 to the proviral 
promoter. These chromatin modifiers are responsible for the deposition of repressive histone 
marks such as H3K9 trimethylation (H3K9me3) and H3K27 trimethylation (H3K27me3) to 
initiate MLV silencing. Ultimately, complete MLV silencing is achieved and maintained by 
DNA methylation. (B) ZFP809 is not expressed in differentiated cells, hence no MLV silencing 
is observed. 






Yin Yang 1 (YY1) 
 Yin Yang 1 (YY1) is a ubiquitously expressed DNA/RNA binding transcription factor 
that takes its name from its dual activity on the adeno-associated virus (AAV) P5 promoter, 
where the presence of adenoviral protein E1A converts YY1 from a transcriptional repressor to 
an activator (Shi et al, 1991). In mice, targeted deletion of YY1 results in peri-implantation 
lethality, indicative of an essential role in embryogenesis (Donohoe et al, 1999). YY1 binds to 
DNA through the recognition of a specific consensus sequence, leading to the activation or 
repression of many cellular genes including c-Myc, c-Fos, -actin, IFN-, CREB, Sp1 and others 
(Gordon et al, 2006; Shi et al, 1997). Moreover, YY1 has been shown to physically interact with 
numerous proteins required for cell growth, apoptosis and cancer progression, including p53, 
Mdm2, Ezh2, and Rb (Gordon et al, 2006; Shi et al, 1997). In Xenopus oocytes, YY1 has been 
demonstrated to associate with structurally divergent RNA species (Belak et al, 2008), raising 
the possibility that YY1 can bind both DNA and RNA. Highlighting this dual-binding property, 
YY1 was shown to tether Xist, a noncoding RNA (lncRNA), to DNA regions on the X 
chromosome, leading to X chromosome inactivation in maternal cells (Jeon & Lee, 2011). 
Therefore, it appears that the zinc finger domain of YY1 can simultaneously bind different 
nucleic acid motifs in Xist RNA and DNA (Jeon & Lee, 2011).  
Apart from its function on cellular promoters, YY1 plays a critical role in the 
transcriptional regulation of retroviral promoters. For example, YY1 binds to and represses the 
HIV-1 promoter, thereby maintaining the virus in a latent state (Bernhard et al, 2013; Margolis et 
al, 1994). As discussed above, in the case of MLV, YY1 directly binds to the negative control 
region (NCR) in the viral LTR (Flanagan et al, 1992), leading to transcriptional silencing of 




transcriptional activation, YY1 potentiates expression from the Human T-lymphotropic Virus 1 
(HTLV-1) promoter, likely through association with the HTLV-1 RNA (Wang GZ and Goff SP, 
unpublished observations). 
 The sequence-specific DNA binding activity of YY1 is mediated by four C2H2-type zinc 
finger motifs (amino acid 298-414) located in the C-terminus (Hariharan et al, 1991). Besides 
their role in DNA binding, portions of the zinc finger motifs (amino acid 333-397), together with 
a region rich in alanine and glycine (amino acid 157-201) contributes to transcriptional 
repression (Bushmeyer et al, 1995; Galvin & Shi, 1997). The N-terminal region contains several 
unusual features also required for transcriptional activation. This includes two stretches of acidic 
residues (amino acids 16-29 and amino acid 43-53), followed by a glycine rich region (amino 
acid 54-69), 11 consecutive histidine residues (amino acid 70-80), and sequences rich in proline 
and glutamine (amino acid 80-100) (Austen et al, 1997; Bushmeyer et al, 1995; Lee et al, 1995; 
Lee et al, 1994). 
Despite the wealth of knowledge garnered about YY1 interacting proteins and target 
promoters regulated by YY1, much less is known about YY1 regulation. Based on previous 
studies, YY1 appears to be a target of several posttranslational modifications, some of which 
contribute to changes in YY1 activity. Sumoylation of YY1 by PIASy on lysine 288 negatively 
affects the transcriptional activity of YY1 (Deng et al, 2007), while O-linked glycosylation of 
YY1 disrupts its interaction with Rb, leading to enhanced DNA binding (Hiromura et al, 2003). 
Moreover, YY1 also undergoes a complex acetylation/deacetylation cycle that changes its 
affinity for DNA and capacity to interact with histone deacetylases (Yao et al, 2001). In prostate 
cancer cells, nitric oxide (NO) has been shown to facilitate S-nitrosylation of YY1 on cysteine 




2005). Serine/threonine phosphorylation of YY1 occurs during the cell cycle. Specifically, 
threonine 39 is a target of Polo-like kinase 1 (Plk1), but the functional importance of this 
modification remains to determined (Rizkallah et al, 2011b). Phosphorylation of serine 180 and 
184 by Aurora B kinase has been shown to have effects on DNA binding and YY1’s ability to be 
acetylated by histone acetyltransferase p300 (Kassardjian et al, 2012). Finally, phosphorylation 
of threonine 348 and 378 in the DNA binding domain of YY1 by an unknown kinase leads to 






Cross-species restriction of retroviruses 
Successful retroviral infection requires cellular factors to support each phase of the 
retroviral life cycle. Therefore, retroviral tropism is partly dictated by whether the infected cell 
possesses the necessary co-factors to assist viral replication. For example, HIV-1 infects human 
T cells and macrophages efficiently but is unable to infect mouse cells. Multiple steps in the viral 
life cycle are blocked in mouse cells. First, the mouse homologues of the human T cell receptors 
and coreceptors CD4, CXCR4 and CCR5 (Atchison et al, 1996; Landau et al, 1988) cannot bind 
the HIV env-encoded gp120, preventing HIV-1 from entering the cell.  This entry block can be 
bypassed in engineered mouse cell lines expressing the human T-cell receptors (Browning et al, 
1997; Clayton et al, 1988), or alternatively, by pseudotyping HIV-1 virions with foreign viral 
envelope proteins such as the glycoprotein G of the vesicular stomatitis virus (VSV-G). Upon 
establishment of the provirus in mouse cells, the late phase of the HIV-1 life cycle is hindered by 
additional cellular blocks. Transcription initiated in the Long Terminal Repeat (LTR) is defective 
due to the incompatibility of the HIV-1 Tat transactivator with mouse cyclin T1 (Fujinaga et al, 
1999; Garber et al, 1998; Kwak et al, 1999; Wei et al, 1998). In addition, viral assembly is 
defective due to the absence of necessary factors required for late stages of the retroviral life 
cycle, a phenotype that can be rescued by the fusion of uninfected human cells with infected 
mouse cells (Bieniasz & Cullen, 2000; Mariani et al, 2001; Mariani et al, 2000). Study of blocks 
to HIV-1 replication in mouse cells has led to the identification and characterization of critical 
cellular factors necessary for infection.  
Species-specific retroviral tropism is also governed by the presence of species-specific 
restriction factors. For example, human and primates are known to be resistant to N-tropic MLV 




was identified as TRIM5 (Perron et al, 2004). In addition to restricting N-tropic MLV, rhesus 
macaque TRIM5 has the remarkable ability to restrict HIV-1 infection (Stremlau et al, 2004; 
Yap et al, 2004). This observation was later attributed to species-specific variations in the 
TRIM5 sequence (Sawyer et al, 2005; Stremlau et al, 2005; Yap et al, 2005), supporting the 
notion that species-specific restriction factors are a major determinant of retroviral tropism. 
Mechanistically, TRIM5 has been proposed to interact with the viral capsid (CA) (Sebastian & 
Luban, 2005), leading to premature dissociation of viral cores (Stremlau et al, 2006), and 
terminating infection prior to nuclear entry (Stremlau et al, 2004). In mice, the Friend virus 
susceptibility factor 1 (Fv1) gene functions similarly to TRIM5. Fv1 encodes a gag-like protein 
with homologies to the ERV-L family of endogenous retroviruses (Best et al, 1996). There are 
two major naturally occurring alleles of Fv1. NIH Swiss mice carry the Fv1
n
 allele, which 
restricts the replication of B-tropic MLVs but not N-tropic MLVs. In contrast, BALB/c mice 
carry the Fv1
b
 allele, which confers resistance to N-tropic MLV infection but not B-tropic MLVs 
(Goff, 1996; Stoye, 1998). A few laboratory mice and some wild mice carry a third Fv1 allele, 
Fv1
nr
, which restricts the replication of B-tropic MLVs and a subset of N-tropic MLVs (Kozak, 




Concluding remarks – setting the stage for projects addressing virus-host interactions at 
multiple steps of the early viral life cycle 
For the next few chapters, I will share my published work on different facets of the retroviral life 
cycle. Chapter 2 and 3 focus on the regulation of gene expression from the MLV promoter in 
mouse embryonic cells. In chapter 2, I will describe a novel ZFP809 interacting protein, EBP1, 
and its involvement in potentiating MLV silencing in mouse embryonic cells. In chapter 3, I 
discuss regulation of YY1 activity through tyrosine phosphorylation, and its implications in the 
control of viral and cellular promoters. Chapters 4 and 5 will move away from retroviral gene 
expression and focus on other early events of infection. In chapter 4, I describe the ability of 
mouse cells to block infection by betaretroviruses such as M-PMV at the step of viral nuclear 
entry. In chapter 5, I describe the most recent project examining the “state” of the viral DNAs 















CHAPTER 2 – EBP1, A NOVEL HOST FACTOR INVOLVED IN PRIMER BINDING 
















































































CHAPTER 5 – HISTONES ARE RAPIDLY LOADED ONTO UNINTEGRATED 
RETROVIRAL DNAS SOON AFTER NUCLEAR ENTRY 
 
Histones are rapidly loaded onto unintegrated retroviral DNAs 
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 In the early stages of retroviral infection, a DNA copy of the viral genome is formed by 
reverse transcription of the RNA genome. The course of DNA synthesis take place in the 
cytoplasm in the context of a large structure closely resembling the virion core. The product of 
this reaction is a fully double-stranded linear DNA contained within a pre-integration complex 
(PIC), which retains many copies of the viral capsid (CA) and nucleocapsid (NC) proteins. The 
linear viral DNA is delivered into the nucleus by routes that differ among virus strains. A portion 
of the linear DNA then gives rise to circular double-stranded DNAs containing either one or two 
copies of the Long Terminal Repeat (LTR) sequences, and a portion is inserted into the host 
genome to form the integrated provirus. The proviral DNA eventually becomes covered with 
nucleosomes, and depending on the cell type, the histone tails of the nucleosomes are modified 
by the addition of histone marks that regulate the expression of the viral DNA. The timing of 
nucleosome loading onto the viral DNA and, in particular, whether nucleosomes are loaded onto 
unintegrated viral DNAs, has not been determined.  In this study, we show that unintegrated viral 
DNAs of Moloney murine leukemia virus rapidly associate with core histones. Loading of 
nucleosomes on the viral DNA requires nuclear entry but does not require viral DNA integration. 
Moreover, we observe that histone loading is correlated with unloading of viral structural 
proteins from the viral DNA. The histones associated with unintegrated DNAs are marked by 
covalent modifications, but the appearance of the modified histones is delayed relative to the 
time of core histone loading. Expression from the unintegrated DNA can be enhanced by 
modulation of the histone modifying machinery. Together, our data show that histones are 







 DNA of eukaryotic chromosomes is condensed into chromatin by the association with 
nucleosomes, each consisting of an octomeric complex of the four core histones. Nucleosomes 
are normally loaded onto chromosomal DNA during the course of DNA replication 
(Ramachandran & Henikoff, 2015) . As a replication fork moves along the DNA, nucleosomes 
are displaced from the unreplicated DNA ahead of the fork and then must reassociate onto both 
daughter branches behind the growing fork. The current models suggest that the relocalization of 
the nucleosomes is a highly dynamic process in which the “old” nucleosomes are distributed to 
both daughter branches, and “new” nucleosomes are added to restore normal nucleosome density. 
During this process, epigenetic marks on the old chromatin must be preserved or reestablished on 
the new DNAs to ensure maintenance of the appropriate pattern of gene expression (Zhu & 
Reinberg, 2011). New nucleosomes may also be loaded at sites of DNA damage, perhaps under 
the direction of the PCNA factor present at the sites. The loading of nucleosomes is thought to be 
promoted by an array of dedicated chaperones, including CAF-1, ATRX, and DAXX (Burgess & 
Zhang, 2013). In contrast to these normal settings of chromatin formation, there are unusual 
circumstances when naked DNA, or DNA previously free of nucleosomes, enters a cell and must 
acquire a nucleosomal array de novo. In these situations there are no “old” or preexisting 
nucleosomes to seed or facilitate the loading of new nucleosomes onto the DNA. One such 
circumstance occurs in the course of retroviral infection.  
 Retroviruses are single-stranded RNA viruses with a complex life cycle. The core of the 
mature virion particle consists of a protein shell made up of the viral capsid protein (CA) 
enclosing two copies of the RNA genome tightly associated with the viral nucleocapsid protein 




and condenses while the CA protein forms a hexameric lattice that encapsidates the viral RNA. 
Following viral entry into the target cell, the single-stranded viral RNA genome is copied by 
reverse transcriptase (RT) to generate a linear double-stranded DNA version of the genome, 
contained within a large complex termed the preintegration complex (PIC). Following the 
completion of reverse transcription, the double-stranded viral DNA and its associated proteins 
are trafficked into the nucleus of the infected cell by one of a variety of mechanisms that vary 
among different viral genera. For example, gammaretroviruses such as Moloney murine 
leukemia virus (MLV) are unable to enter the intact nucleus of a nondividing cell and depend on 
nuclear membrane breakdown during cell division to gain entry (Roe et al, 1993). In contrast, 
lentiviruses such as HIV-1 are actively transported across the nuclear membrane even in non-
dividing cells such as macrophages and resting T lymphocytes (Weinberg et al, 1991). The 
distinct requirements for nuclear entry also serve as a point of restriction for cross-species 
transmission of retroviruses. For example, betaretroviruses such as Mason-Pfizer monkey virus 
(M-PMV) are unable to enter the nucleus of mouse cells, defining a potent cross-species block at 
this step of the viral life cycle (Wang & Goff, 2015).  
Once inside the nucleus, viral encoded integrase (IN) enzyme catalyzes the insertion of 
linear viral DNAs into the host chromosomes. The integration reaction proceeds in two steps. 
First, IN catalyzes the removal of two nucleotides from the 3’ terminus of the viral long terminal 
repeat (LTR), termed 3’-end processing (Brown et al, 1989; Roth et al, 1989). The resultant viral 
DNA substrate is then joined to the target DNA on host chromosomes through a strand transfer 
reaction (Craigie et al, 1990; Engelman et al, 1991). Structurally, the catalytic pocket of IN from 




the D-D(35)-E motif (e.g. D184A) results in the loss of all catalytic activities, making it a useful 
tool to study integration independent viral processes (Lai et al, 2001).  
Homologous recombination of linear viral DNAs at the LTR leads to the formation of 1-
LTR circles. 2-LTR circles, containing full length viral DNA and both sets of LTRs arranged 
back to back, are products of non-homologous end joining (NHEJ) DNA repair pathways in the 
nucleus. This property makes 2-LTR circles a useful marker of viral nuclear import, as the 
unique nature of the LTR-LTR junction allow their levels to be readily quantified by PCR 
(Butler et al, 2001).  
In permissive cells, following integration, the 5’ LTR of the proviral DNA serves as the 
promoter to generate full-length genomic viral mRNAs necessary for viral gene expression and 
genome replication. However, certain cell types possess the ability to block this step of the 
retroviral life cycle. For example, MLV is unable to replicate in mouse embryonic stem (ES) or 
embryonic carcinoma (EC) cells (Akgun et al, 1991; Hilberg et al, 1987; Linney et al, 1984). In 
embryonic cells, reverse transcription and proviral integration proceed normally, but viral 
transcription is repressed, and hence no viral gene products can be detected. One major 
mechanism in the transcriptional silencing of MLV in embryonic cells involves the recruitment 
of trans-acting transcriptional repressors such as ZFP809, Trim28, YY1 and Ebp1 (Rowe et al, 
2010; Schlesinger et al, 2013; Wang et al, 2014; Wolf & Goff, 2007; Wolf & Goff, 2009) to 
DNA binding sites on the viral LTR. This results in the recruitment of chromatin modifiers such 
as SETDB1 (Matsui et al, 2010), which deposits repressive histone marks such as H3K9 
trimethylation (H3K9me3) en route to complete promoter silencing. 
Several fundamental aspects of retroviral replication remain unexplored. Given that 




what is the histone state of these retroviral DNAs following infection. Are retroviral DNAs a 
target of histone loading? If so, when, where and on what forms of viral DNA does this occur? 
Following reverse transcription, do retroviral DNAs remain associated with their cognate 
structural proteins such as NC and CA? When and where does NC and CA dissociate from the 
viral DNA?    
In this study, using MLV as a model, we describe the kinetics of histone association with 
the viral DNA genomes. We show that unintegrated linear viral DNAs and 2-LTR circles 
undergo rapid core histone loading in a nuclear entry-dependent and integration-independent 
manner. Moreover, histone loading appears to be correlated with the removal of viral structural 
proteins such as NC and CA from the viral DNA. In contrast to core histone loading, loading of 
epigenetically modified histones occurs after a delay, thereby postponing host cell regulation of 
the viral promoter. Finally, we show that unintegrated viral DNAs do give rise to a low level of 
gene expression, and that this expression can be increased by changing the activity of chromatin 







Core histone loading onto retroviral DNAs occurs rapidly following infection 
To investigate histone loading onto viral DNA genomes following infection, we utilized a 
single-round MLV reporter genome in which viral genes were replaced with the GFP gene 
(MLV-GFP). Virions capable of infecting a wide range of cell lines were prepared by collecting 
culture medium after transfection of 293T cells with plasmids encoding the MLV-GFP reporter 
genome, the MLV gag-pol protein, and the VSV-G envelope protein. This reporter virus is 
capable of carrying out all the early events of a single round of infection, including reverse 
transcription, nuclear entry, integration, and reporter gene expression. Kinetic studies 
characterizing the formation of viral DNA replication intermediates following infection were 
first performed. Mouse embryonic fibroblasts (MEFs) were transduced with MLV-GFP reporter 
virus, total DNA was harvested at 12, 24 h or 6 days post infection, and levels of viral DNA 
replication intermediates was monitored by quantitative real-time PCR using primers specific for 
GFP (to detect total viral DNA) or 2-LTR circles (a marker of nuclear entry) (Fig. 1A). To 
control for potential plasmid DNA carryover in the viral preparation, transduction of MEFs with 
heat inactivated (HI) virus were carried out in parallel. Total viral DNA, which includes linear 
DNA, circular DNA, and integrated proviral DNA, appeared at 12 h post infection, rose to a peak 
at 24 h, and then decreased to a stable copy number of approximately 3200 copies by 6 days (Fig 
1A). The 2-LTR circles appeared later, rose to a peak at 24 h post infection, and was completely 
undetectable by 6 days, indicative of their short half-life in the nucleus (Fig. 1B). Of note, the 
maximum amount of 2-LTR circles at early time points accounts for 10-20% of total viral DNAs. 
As negative controls, MEFs transduced with heat-inactivated virus yielded no PCR signal, 




We next monitored the association of nucleosomal histone H3 with retroviral DNAs by 
Chromatin immunoprecipitation (ChIP). Infected MEF cells were formaldehyde cross-linked at 
12, 24 h, and 6 days post infection, and processed to yield chromatin of appropriate size (200-
800 base pairs). Chromatin immunoprecipitation (ChIP) assays were performed with antibodies 
specific for histone H3 or non-specific IgG control, followed by quantitative real-time PCR 
analysis of immunoprecipitated DNA using primers targeting GFP (total viral DNA) or 2-LTR 
circles. As a positive control, PCR primers targeting the promoter region of endogenous GAPDH 
gene were used to represent fully chromatinized cellular DNA. Approximately 10% of the 
GAPDH promoter sequences were specifically immunoprecipitated with the anti-histone H3 
antibody, but not the non-specific IgG control antibody (Fig. 1B). Assuming that the GAPDH 
promoter is fully chromatinized at all times, these results suggests that our ChIP recovery 
efficiency is approximately 10%. In the case of viral DNAs, we detected rapid association of 
histone H3 with total viral DNA to levels comparable to that of the cellular GAPDH gene by 24 
h post infection (Fig. 1B). At 6 days, the observed ChIP signal with the GFP probe (total viral 
DNA) remained high, indicative of fully chromatinized proviral DNA. In the case of 2-LTR 
circles, histone H3 loading reached similar levels to that of the cellular GAPDH gene by 12 h 
post infection (Fig. 1B). Of note, the signal of chromatin-bound DNA in the total DNA was too 
high to be accounted for only by the circular DNAs, thusthe majority of the signal must be 
derived from the linear form. Similar kinetics of histone loading onto viral DNAs were observed 
in MLV-GFP infected F9 embryonic carcinoma cells (Fig. 1C and 1D). Together, these findings 
suggest that both total and circular retroviral DNA forms undergo rapid chromatinization 





Histone loading of retroviral DNAs occurs independently of viral integration 
 To investigate whether viral integration is needed for efficient histone loading, two 
independent approaches were taken. First, MLV-GFP reporter viruses were packaged using wild-
type (WT) or catalytically inactive MLV integrase (IN) mutant (D184A) (Lai et al, 2001). The 
infectivity of WT or D184A-IN virions was confirmed using flow cytometry analysis of infected 
NIH-3T3 fibroblasts 48 h post infection (Fig. 2B). Compared to WT virus, a 70-fold reduction in 
the infectivity of D184A-IN virions was observed (Fig. 2B). Moreover, cells infected with 
D184A-IN virions contained slightly higher levels of total viral DNA (GFP) and 2-LTR circles at 
12 and 24 h post infection, but no viral DNA was detected at 6 days post infection (Fig. 2C). 
This suggests that the D184A mutation has no adverse effects on reverse transcription and viral 
nuclear entry, but is defective in viral integration. Compared to WT virus, histone H3 ChIP of 
cells infected with D184A-IN virus showed comparable accumulation of histone H3 on both 
total viral DNA (GFP) and 2-LTR circles (Fig. 2D). This observation suggests that viral 
integration is not required for histone loading and that most of the chromatinized viral DNA 
early on likely represent unintegrated linear and circular DNA forms.   
Alternatively, similar ChIP experiments were performed on MEF cells infected with WT-
virus in presence or absence of the integrase inhibitor raltegravir (Fig. 2E). As expected, 
raltegravir treatment prevented the formation of GFP
+
 cells (Fig. 2F). Analogous to the case for 
D184A-IN virus, raltegravir treatment caused a 2-fold increase in the levels of 2-LTR circles 
without affecting total viral DNA (GFP) levels (Fig. 2G). Compared to mock treated cells, ChIP 
analysis using raltegravir treated cells revealed normal accumulation of histone H3 on both total 




integration. Taken together, our data suggests that early during infection, chromatinization of 
total viral DNA occurs irrespective of viral integration.  
 
Histone loading of retroviral DNAs requires viral nuclear entry 
It is well established that 2-LTR circles, products of host cell non-homologous end 
joining, are found exclusively in the nucleus, making it a useful marker for viral nuclear entry 
(Bukrinsky et al, 1992; Bukrinsky et al, 1991; Shoemaker et al, 1980). Like many nuclear 
proteins, histones are first synthesized in the cytosol and later trafficked to the nucleus (Burgess 
& Zhang, 2013). Since viral reverse transcription also takes place in the cytoplasm and that 
linear viral DNA is able to undergo rapid chromatinization following infection (Fig. 2D and 2H), 
we examined the possibility that histone loading onto viral DNAs may occur in the cytoplasm 
prior to viral nuclear entry. Previously, it has been shown that in mitotically active cells, nuclear 
envelope breakdown facilitates entry of the MLV preintegration complex (PIC) into the nucleus, 
while growth arrested cells that fail to undergo cell division block MLV infection at nuclear 
entry (Roe et al, 1993). To block nuclear entry, NIH-3T3 cells were treated with or without 
aphidicolin, a reversible inhibitor of eukaryotic DNA synthesis for 24 h (Fig. 3A). DNA content 
analysis of aphidicolin treated cells using fluorescence activated cell sorting (FACS) revealed 
cell cycle arrest in the G1/S phase (Fig. 3B). Growth arrested cells were then transduced with 
MLV-GFP reporter viruses for 24 h, after which chromatin from infected cells was subjected to 
ChIP using histone H3 antibodies. At 24 h post infection, aphidicolin treatment did not affect 
levels of total viral DNA (GFP), hence suggesting that viral entry, uncoating and reverse 
transcription proceeded normally (Fig. 3C). In contrast, a 30-fold reduction in the levels of 2-




despite normal levels of input total viral DNA, ChIP analysis revealed a 10-fold reduction in 
histone H3 associated viral DNA in aphidicolin arrested cells, whereas histone H3 coverage of 
the cellular GAPDH gene was unaffected by the drug (Fig. 3C).   
 To further address the nuclear entry requirement for retroviral histone loading, we took 
advantage of our earlier finding that mouse cells exhibit a nuclear entry block to Mason-Pfizer 
monkey virus (M-PMV) infection (Wang & Goff, 2015). Mouse Ba/F3 cells, a pro-B cell line, 
were infected with VSV-G pseudotyped MLV-GFP or M-PMV-GFP (Fig. 3E), and the 
efficiency of infection was monitored by flow cytometry analysis 48 h later (Fig. 3F). Compared 
to MLV, Ba/F3 cells show a 100-fold block to M-PMV infection (Fig. 3F). Although M-PMV 
infected cells showed normal levels of total viral DNA (GFP), a 60-fold reduction in the 
formation of 2-LTR circles was observed, highlighting a block in nuclear entry (Fig. 3G). 
Importantly, in comparison to MLV, we also observed a 6-fold reduction in histone H3 
association with M-PMV total viral DNA (Fig. 3H). Together, our two independent approaches 
highlight the nuclear entry requirement for efficient histone loading onto viral DNAs.    
 
Loading of epigenetically modified histones onto viral DNAs is delayed compared to core 
histones 
To extend our above observation that retroviral DNAs undergo rapid association with 
core histone H3 early during infection, we next examined the kinetics of epigenetically modified 
histone loading onto retroviral DNAs. To do this, we made use of a previously established MLV 
transcriptional silencing phenomenon in F9 mouse embryonic carcinoma cells. Flow cytometry 
analysis of F9 cells transduced with MLV-GFP at various times post-infection is depicted in Fig. 




of the cells were GFP
+
 (Fig. 4A). This data suggest that there is a lag to complete promoter 
silencing. Based on this, we hypothesized that the delay in MLV silencing may be due to the 
absence of repressive histone marks on the viral DNA. To test this, ChIP analysis from infected 
cells were carried out using antibodies against histone H3K9 trimethylation (H3K9me3), a 
marker of silenced chromatin, or acetyl-histone H3 (H3Ac), a marker of active chromatin, 
followed by quantitative real-time PCR analysis using the indicated primers (Fig. 4B). As 
controls, the specificity of these antibodies for ChIP was confirmed using positive control 
primers specific for endogenous promoters Polrmt (H3K9me3) and GAPDH (H3Ac). During 
early infection, there was very low enrichment of H3K9me3 marks on the viral DNA, consistent 
with the modest number of GFP
+
 cells (Fig. 4B). In contrast, H3K9me3 became highly enriched 
on the viral DNA by 6 days post infection (Fig. 4B), consistent with the complete silencing of 
the viral promoter (Fig. 4A). Conversely, no enrichment of H3Ac marks on viral DNAs was 
observed at all times (Fig. 5C). Together, these results suggest that the kinetics of modified 
histone loading is slower than that of core histone loading, thereby contributing to the delay in 
MLV silencing (Fig. 5A). As expected, deposition of repressive histone marks onto viral DNAs 
is only seen in mouse embryonic cells, as reciprocal experiments in differentiated MEF cells 
showed enrichment of H3Ac (Fig. 4E), but not H3K9me3 (Fig. 4D) marks on the viral DNA at 6 
days post infection, consistent with high MLV gene expression in these cells. 
 
Characterization of the expression of unintegrated MLV DNA in NIH-3T3 cells 
Our findings that unintegrated MLV genomes are rapidly covered with core histones (Fig. 2D 
and 2H) together with the observation that unintegrated MLV genomes show poor gene 




chromatin modifications that prevent the recruitment of host transcriptional machinery. Histone 
acetyltransferases and deacetylases are key components of the eukaryotic transcriptional 
machinery that control the activation or silencing of cellular promoters. Acetylation of histone 
H3 and H4 on lysine residues decrease the protein’s overall positive charge, thereby leading to 
an open chromatin conformation conducive to transcription activation. In contrast, deacetylation 
of histone H3 and H4 leads to chromatin condensation and transcriptional silencing. To test the 
possibility that unintegrated MLV DNA may be deficient in histone acetylation, NIH-3T3 cells 
were first infected with WT or D184A-IN GFP viruses for 24 h, followed by the addition of 
Trichostatin A (TSA), a specific inhibitor of histone deacetylases (Fig. 5A). Interestingly, 
following TSA treatment, GFP expression from cells infected with D184A-IN virus showed a 4-
fold increase in the percentage of GFP
+
 cells as well as a 3-fold increase in the mean 
fluorescence intensity (Fig. 5B, upper panel). In contrast, TSA addition failed to increase GFP 
expression in cells infected with WT-IN viruses (Fig. 5B, lower panel), suggesting that this drug 
only affects expression from unintegrated viral DNAs. We next performed ChIP assays using 
acetylated histone H3 antibodies before and after the addition of TSA in both WT and D184A-IN 
mutant cells. Compared to mock treatment, TSA treatment of D184A-IN infected cells resulted 
in a 4-fold increase in H3 acetylation of linear, but not 2-LTR circles (Fig. 5D). This suggests 
that only linear, but not circular unintegrated viral DNA forms contribute to gene expression. In 
contrast, exposure to TSA did not further increase the extent of histone H3 acetylation in WT-IN 
infected cells (Fig. 5D), perhaps because fully integrated proviral DNA already exhibits high 
enrichment in acetylated H3 marks. Together, these data suggest that gene expression from 




RNA polymerase recruitment, and that the chromatin environment can be corrected by the 
inhibition of histone deacetylases.    
 
Characterization of the kinetics of nucleocapsid (NC) and capsid (CA) association with viral 
DNA following reverse transcription  
The NC proteins of retroviruses are small, highly basic nucleic acid binding proteins that directly 
contacts the RNA genome in the mature virion. Apart from its structural role, proper NC is 
indispensable for many steps of viral replication including viral assembly, genomic RNA 
packaging, reverse transcription and integration (Mori et al, 2015). Here, we examined the fate of 
viral DNAs following infection with respect to its association with NC. ChIP assays using MLV-
NC specific antibodies were performed at different times post infection in infected NIH-3T3 
cells, followed by quantitative real time PCR to monitor the extent of NC association with total 
viral DNA (GFP) and 2-LTR circles (Fig. 6A). Shown in Fig. 6A, highest association of NC with 
the total viral DNA was observed 4 h post infection, followed by a rapid decrease to very low 
levels by 48 h. Of note, no association between NC and 2-LTR circles was detected at all times 
(Fig. 6A). Similar kinetics of association was observed between CA and total viral DNA (Fig. 
6B). In each case, the specificity of the antibodies used for ChIP is confirmed by the lack of non-
specific binding to the cellular GAPDH gene, as well as using cells that were infected with heat 
inactivated (HI) virus (Fig. 6A and 6B).  
 The timing of NC and CA dissociation from the total viral DNAs (Fig. 6A and 6B) 
appears to coincide with the rapid accumulation of core histones (Fig. 1B and 1D). Since histone 
loading of viral DNAs takes place in the nucleus (Fig. 3D and 3H), this raises the possibility that 
upon nuclear entry, core histones may promote the dissociation of NC and CA from the viral 




preventing nuclear entry may result in the stabilization of NC and CA-DNA complexes. Indeed, 
NC and CA ChIP analysis from aphidicolin treated NIH-3T3 cells showed a 3-fold increase in 
NC and CA binding to total viral DNAs (Fig. 6C). This implies that histone and viral protein 





In this study, using MLV as a model for retroviruses, we described for the first time the 
state of the viral DNAs following infection. By performing histone H3 ChIP analysis on murine 
cells infected with MLV, we show that core histone H3 rapidly associates with total viral DNAs 
following infection (Fig. 1B and 1D). Moreover, experiments using either integrase mutant MLV 
or raltegravir treated cells demonstrate that histone loading of total viral DNAs occurs 
independently of viral integration (Fig. 2D and 2H). Total viral DNA is composed of linear DNA, 
a direct product of reverse transcription and a substrate for integration, circular DNA, a marker 
of nuclear entry, and fully integrated proviral DNA. 2-LTR circles constitute 10-15% of total 
viral DNAs (Fig. 1A and 1C), while the remaining is made up of mostly linear DNA, other forms 
of circular DNA, and fully integrated proviral DNA. From this, we deduce that during early 
infection, histone loading of linear DNA must account for a fraction of the total ChIP signal (Fig. 
1B and 1D). Since linear DNA also serve as precursors to 2-LTR circles, one can envision 
several potential mechanisms of histone loading onto 2-LTR circles, including (1) histone 
loading onto linear DNA followed by circularization, (2) circularization followed by histone 
loading, or (3) histone loading and DNA circularization occurring simultaneously. Our current 
data cannot distinguish between these possible modes of histone loading. 
The majority, if not all of the histone loading onto viral DNAs occurs in the nucleus. This 
is supported by our observation that perturbation of viral nuclear entry, either by infecting 
aphidicolin arrested cells with MLV (Fig. 3D), or by infecting mouse cells with M-PMV, a virus 
previously shown to be defective in nuclear entry (Fig. 3H), all caused a marked reduction in the 
extent of histone H3 association with total viral DNAs.   
Using a previously characterized model of MLV promoter silencing in mouse embryonic 




with viral DNAs. In F9 embryonic carcinoma cells, significant core histone loading occurred as 
early as 12 h post infection (Fig. 1D). In contrast, modified histone loading, as measured by the 
presence of H3K9 trimethylation (H3K9me3), became evident much later at 6 days post 
infection (Fig. 4B). The delay in the appearance of modified histones on the viral DNAs 
correlates with the delay in the complete transcriptional silencing of the MLV promoter (Fig. 
4A). In the case of differentiated cells, where the MLV promoter is fully active, acetylated 
histone H3 loading was also found to occur much later at 6 days compared to core histone 
loading as early as 12 h (Fig. 4E). Together, these data suggest that the appearance of both 
repressive and active histone marks occur after core histone loading, thereby causing a transient 
delay in the host cell modulation of viral gene expression. In host cells, DNA replication during 
S-phase is associated with rapid reassembly of nucleosomes and inheritance of parental histone 
modifications (Zentner & Henikoff, 2013). This is achieved by histones around the parental 
DNA strand acting as a template to direct histone modifications of the daughter DNA strand 
(Zhu & Reinberg, 2011). Retroviral infection generates de novo foreign DNA that the cell has 
never seen before, hence the delay in the appearance of histone marks may reflect the absence of 
previously established epigenetic memory, and the timing required to establish it in the first 
place.     
Using a catalytically inactive IN mutant (D184A), we were able to study gene expression 
derived from unintegrated viral DNAs. Under basal conditions, the expression level from 
unintegrated viral DNAs was very low compared to integrated proviral DNAs (Fig. 5B), 
consistent with previous reports (Nakajima et al, 2001; Poon & Chen, 2003). However, the 
addition of HDAC inhibitor TSA following infection caused a marked increase in the expression 




unintegrated DNAs appears to be a product of two mechanisms. First, the increase in gene 
expression from unintegrated viral DNA was accompanied by an increase in the association of 
acetylated histone H3, a marker of actively transcribed genes, with the viral promoter (Fig. 5D), 
thus favoring the recruitment of the host transcriptional machinery. Interestingly, such H3Ac 
enrichment was only observed on total viral DNA, but not 2-LTR circles, implying that the 
enhanced gene expression may be a product of increased transcription from only linear DNA 
templates and not circular forms (Fig. 5D). Secondly, TSA appears to increase the stability of 
unintegrated, but not integrated DNA forms, thereby increasing the amount of viral template 
available for transcription (Fig. 5C). Why this is the case is a topic for future investigations, one 
possibility is that TSA treatment may prolong the half-life of unintegrated DNA forms by 
reducing the activity of the DNA degradation machinery in the nucleus. 
Using antibodies specific for the NC and CA proteins of MLV, we were able to follow 
the kinetics of NC and CA dissociation from the viral DNA following infection (Fig. 6A and 6B). 
High degree of NC and CA association with the viral DNA early during infection followed by 
rapid decay coincides with the timing of histone loading, suggesting that the two events may be 
mutually exclusive. Indeed, by blocking nuclear entry and preventing histone loading, we were 
able to prolong the association of NC and CA with the viral DNAs (Fig. 6C). One possible 
model is that following entry of viral DNAs into the nucleus, core histones may compete with 
NC and CA for binding to the viral DNAs, leading to their disassembly (Fig. 7C).  
The precise mechanism by which core histones are loaded onto retroviral DNAs remains 
a mystery, and likely requires the activity of cellular histone chaperones. Since retroviral 
infection generates newly synthesized DNA through reverse transcription, one may predict that 




during DNA replication. For cellular DNA, the Caf1 complex is thought to mediated de novo 
histone H3/H4 assembly of newly synthesized DNA during replication (Gaillard et al, 1996; 
Kaufman et al, 1995). However, preliminary experiments using Caf1 knockdown cells showed 
no impairment in the extent of histone loading onto viral DNAs (data not shown), highlighting 
the likely involvement of other chaperones, a topic of future studies. Equally interesting is the 
question of whether viral encoded proteins play a role in facilitating histone loading onto its own 
DNA. 
Future studies will be aimed at elucidating the effect of histone loading on the retroviral 
replication potential. For instance, does histone loading protects linear DNA from degradation? 
Does histone loading of linear DNA promote efficient integration or integration site selection? 
Answering these questions will require an understanding of the cellular machinery responsible 




MATERIALS AND METHODS 
Cell lines and antibodies 
Cell lines including human embryonic kidney (HEK)-293 (CRL-1573), F9 embryonic carcinoma 
(CRL-1720), Mouse embryonic fibroblasts (MEF) (SCRC-1008) and NIH-3T3 (CRL-1658) cells 
were purchased from American Type Culture Collection. All cells were cultured in Dulbecco’s 
modified Eagle’s Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum 
(FBS), 2 mM glutamine, 1000 U/mL penicillin and 100 mg/mL streptomycin. Ba/F3 cells were 
cultured in RPMI medium supplemented with 10% heat-inactivated FBS and 1.6 ng/mL of 
recombinant IL-3 (R&D Systems). All cells were maintained in a 37°C incubator with 5% CO2. 
Antibodies used in this study include: Anti-Histone H3 (ab1791, Abcam), Anti-Histone H3 tri-
methyl K9 (ab8898, Abcam), Anti-Acetyl-Histone H3 (06-599, Millipore), anti-MLV NC 
(National Cancer Institute serum 79S-), anti-MLV CA (National Cancer Institute serum 79S-804) 
and rabbit IgG control antibody (sc-2027, Santa Cruz).  
 
Plasmids  
pCMV-intron expresses wild-type gag and pol from NB-tropic MLV (Soneoka et al, 1995). 
pCMV-intron D184A-IN is an integrase dead mutant of pCMV-intron created by site directed 
mutagenesis. pMD.G expresses the vesicular stomatitis virus (VSV) envelope glycoprotein. 
pNCA-GFP is a replication-defective single-round MLV vector described previously (Ooi et al, 
2010). pSARM-EGFP is a replication-defective single-round M-PMV vector in which the env 
gene has been replaced with EGFP as described (Newman et al, 2006). 
 




NB-tropic MLV-GFP reporter viruses were produced by 293T cell transfection with 8 g of 
pNCA-GFP, 4 g of pCMV-intron, and 4 g of pMD.G DNAs using Polyethylenimine (PEI). 
Similarly, M-PMV-GFP reporter viruses were produced by transfection of 293T cells with 12 g 
of pSARM-EGFP and 4 g of pMD.G. All reporter viruses were harvested 48 h later, filtered 
(0.45 m), DNase treated for 1 h (Turbo DNase, Thermo Scientific), and used directly for 
transduction assays as described previously (Wang & Goff, 2015). For some experiments, 10 M 
of raltegravir (Santa Cruz Biotechnology) was added to the culture medium for the entire 
duration of infection. Forty-eight hours post-infection, cells were trypsinized, diluted using flow 
cytometry buffer (PBS with 1% BSA), and subjected to flow cytometry using automated cell 





 cells were crosslinked with 1% formaldehyde at room temperature for 10 min, followed 
by quenching with 0.125M glycine for 5 min. Cells were lysed in 0.5 mL of ChIP lysis buffer 
(50mM Tris-HCl pH 8.0, 1% SDS, 10 mM EDTA) containing Protease inhibitor cocktail (Roche) 
and sonicated to produce an average fragment size of 200–800 base pairs. Each 
immunoprecipitation was performed by incubating 30 g of sonicated chromatin together with 4 
g of respective antibodies in ChIP dilution buffer (10 mM Tris-HCl pH 8.0, 1% Triton X-100, 
0.1% SDS, 150 mM NaCl, 2 mM EDTA) overnight at 4°C. Next day, 25 μl of Protein A/G 
Dynabeads (Life Technologies) were added for an additional 4 h. Captured antibody-antigen 
complexes were washed 2 times each in ChIP low salt buffer (20 mM Tris-HCl pH 8.0, 1% 
Triton X-100, 0.1% SDS, 150 mM NaCl, 2 mM EDTA), ChIP high salt buffer (20 mM Tris-HCl 




Tris-HCl pH 8.0, 1% NP-40, 250 mM LiCl, 1 mM EDTA), and TE buffer (10 mM Tris-HCl pH 
8.0, 1 mM EDTA). DNA was eluted from beads in 200 μl elution buffer (TE buffer containing 1% 
SDS, 100 mM NaCl, 5mM DTT), reverse crosslinked (65°C overnight), treated with RNase A 
(37°C, 1 h) and Proteinase K (37°C, 2 h), and purified using QIAquick PCR purification kit 
according to the manufacturer’s instructions (Qiagen). Quantitative real-time PCRs were 
performed with indicated primers. The number of copies of each PCR product in both input and 
immunoprecipitated DNA was first determined using plasmid derived standard curves. Relative 
enrichment is shown as percent of input DNA calculated by dividing the number of copies from 
immunoprecipitated DNA by input DNA and multiplying it by 100%. 
 
Quantitative real-time PCR analysis of viral replication intermediates 
At various time points following infection, cells were washed with PBS, and total DNA was 
isolated using Qiagen DNeasy kit according to the manufacturer’s instructions. For analysis of 
viral replication intermediates, 75 ng of total DNA was mixed with SYBR Green PCR master 
mix (Roche) containing 15 pmol of indicated primers (see Supplemental table 1). PCRs were 
performed in 96-well plates using 7900 Fast Real-Time PCR system (Applied Biosystems) with 
the following reaction conditions: 10 min at 95°C, followed by 45 cycles of 30 s at 95°C, 30 s at 
60°C and 30 s at 72°C. For all reactions, the number of copies of each PCR product was 
determined using plasmid derived standard curves. 
 
Aphidicolin treatment and cell cycle analysis of DNA content  
NIH-3T3 cells were treated with aphidicolin (Sigma, 2 g/mL) for 24 h prior to infection. 




stained with Hoechst 33342 (Invitrogen) at 1 g/mL in cell culture medium for 30 min at 37°C, 
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FIGURE 1. Core histone loading onto retroviral DNAs occur rapidly following infection 
(A) MEF cells were infected with VSV-G pseudotyped MLV-GFP reporter virus. To control for 
potential plasmid DNA carry over in the viral supernatant, heat inactivated (HI) virus were used 
in parallel. Total DNA from infected cells was isolated at indicated time points, followed by real 
time quantitative PCR using primers targeting GFP (total viral DNA) and 2-LTR circles. 
Absolute copy number is calculated based on standard curves generated using plasmid DNA. 
Results shown are means ± SDs from two independent experiments performed in duplicates. 
(B) Histone H3 chromatin immunoprecipitation (ChIP) analysis of chromatin harvested at 
indicated time points following MLV-GFP infection of MEF cells. ChIP data is presented as % 
of input DNA, calculated by dividing the ChIP copy number for each gene target by the copy 
number from input DNA and multiplying by 100%. Results shown are means ± SDs from two 
independent experiments performed in duplicates. ND denotes not determined. 
(C) ChIP analysis as outlined in (B) using rabbit IgG control antibody. 
(D) Same experiment as outlined in (A) using F9 embryonic carcinoma cells. 
(E) Same experiment as outlined in (B) using F9 embryonic carcinoma cells. 
(F) Same experiment as outlined in (C) using F9 embryonic carcinoma cells. 
 
FIGURE 2. Histone loading of retroviral DNAs occurs independently of viral integration 
(A) Schematic of experimental setup. 
(B) Flow cytometry analysis of NIH-3T3 cells infected with VSV-G pseudotyped wild-type (WT) 
or integrase dead mutant (D184A) MLV-GFP reporter viruses. This is 2 days post infection. Y-
axis shows side scatter (SSC), X-axis shows GFP
 
intensity. One representative experiment of 
three independent experiments is shown. 
(C) NIH-3T3 cells were infected with VSV-G pseudotyped wild-type (WT) or integrase dead 
mutant (D184A) MLV-GFP reporter viruses. Total DNA from infected cells was isolated at 
indicated time points post infection and number of copies of viral replication intermediates was 
determined as described above. Results shown are means ± SDs from two independent 
experiments performed in duplicates.  
(D) Histone H3 ChIP analysis of chromatin harvested at indicated time points following MLV-




Results shown are means ± SDs from two independent experiments performed in duplicates. ND 
denotes not determined. 
(E) Schematic of experimental setup. 
(F) Flow cytometry analysis of MEF cells infected with VSV-G pseudotyped WT MLV-GFP 
reporter viruses in the presence or absence of raltegravir (Ral). This is 2 days post infection. Y-
axis shows side scatter (SSC), X-axis shows GFP
 
intensity. One representative experiment of 
three independent experiments is shown. 
(G) MEF cells were infected with VSV-G pseudotyped wild-type (WT) MLV-GFP reporter 
viruses in the presence or absence of raltegravir (Ral). Total DNA from infected cells was 
isolated at indicated time points post infection and the number of copies of viral replication 
intermediates was determined as described above. Results shown are means ± SDs from two 
independent experiments performed in duplicates. 
(H) Histone H3 ChIP analysis of chromatin harvested at indicated time points following MLV-
GFP infection of MEF cells treated with or without raltegravir (Ral). ChIP data is presented as % 
of input DNA as described above. Results shown are means ± SDs from two independent 
experiments performed in duplicates. ND denotes not determined. 
 
FIGURE 3. Histone loading of retroviral DNAs requires viral nuclear entry 
(A) Schematic of experimental setup. 
(B) Cell cycle analysis of NIH-3T3 cells treated with or without DNA polymerase inhibitor 
aphidicolin for 24 h prior to infection. Y-axis shows cell count, X-axis shows DNA content 
measured by Hoechst staining. One representative experiment of three independent experiments 
is shown. 
(C) NIH-3T3 cells pretreated with or without aphidicolin (Aph) to induce cell cycle arrest were 
infected with VSV-G pseudotyped WT MLV-GFP reporter virus. Total DNA from infected cells 
was isolated 24 h post infection and the levels of viral replication intermediates were determined 
as described above. Results shown are means ± SDs from two independent experiments 
performed in duplicates. 
(D) Histone H3 ChIP analysis of chromatin harvested from NIH-3T3 cells outlined in (C) 24 h 
post infection. ChIP data is presented as % of input DNA as described above. Results shown are 
means ± SDs from two independent experiments performed in duplicates. ND denotes not 
determined. 




(F) Flow cytometry analysis of Ba/F3 cells infected with VSV-G pseudotyped single-round 
MLV or M-PMV-GFP reporter viruses. This is 2 days post infection. Y-axis shows side scatter 
(SSC), X-axis shows GFP
 
intensity. One representative experiment of three independent 
experiments is shown. 
(G) Level of viral replication intermediates from Ba/F3 cells infected with MLV or M-PMV-
GFP reporter viruses. Total DNA from infected cells was isolated at indicated time points post 
infection and number of copies of viral replication intermediates was determined as described 
above. Results shown are means ± SDs from two independent experiments performed in 
duplicates. 
(H) Histone H3 ChIP analysis of chromatin harvested from infected Ba/F3 cells outlined in (G). 
ChIP data is presented as % of input DNA as described above. Results shown are means ± SDs 
from two independent experiments performed in duplicates. ND denotes not determined. 
 
FIGURE 4. Loading of epigenetically modified histones onto viral DNAs is delayed compared 
to core histones 
 
(A) Flow cytometry analysis of F9 cells infected with VSV-G pseudotyped WT MLV-GFP 
reporter viruses at the indicated time points. Y-axis shows side scatter (SSC), X-axis shows GFP
 
intensity. One representative experiment of three independent experiments is shown. 
(B) H3K9 trimethylation (H3K9me3) ChIP analysis of infected F9 cells at the indicated time 
points. ChIP data is presented as % of input DNA as described above. Results shown are means 
± SDs from two independent experiments performed in duplicates. Mitochondrial DNA 
polymerase (positive control gene), GAPDH (negative control gene). ND denotes not determined.  
(C) Acetyl-histone H3 (H3Ac) ChIP analysis of infected F9 cells at the indicated time points. 
ChIP data is presented as % of input DNA as described above. Results shown are means ± SDs 
from two independent experiments performed in duplicates. Mitochondrial DNA polymerase 
(negative control gene), GAPDH (positive control gene). ND denotes not determined. 
(D) Similar experiment as (B) performed in MEF cells. 
(E) Similar experiment as (C) performed in MEF cells. 
 
FIGURE 5. Characterization of the expression of unintegrated MLV DNA in NIH-3T3 cells 




(B) Flow cytometry analysis of NIH-3T3 cells infected with VSV-G pseudotyped wild-type (WT) 
or integrase dead mutant (D184A) MLV-GFP reporter viruses in the presence or absence of TSA 
treatment. This is 2 days post TSA treatment. Y-axis shows side scatter (SSC), X-axis shows 
GFP
 
intensity. One representative experiment of three independent experiments is shown. 
(C) NIH-3T3 cells infected with VSV-G pseudotyped WT or integrase dead mutant (D184A) 
MLV-GFP reporter virus and each treated with or without TSA. Total DNA from infected cells 
was isolated at indicated time points and levels of viral replication intermediates were 
determined as described above. Results shown are means ± SDs from two independent 
experiments performed in duplicates. 
(D) H3Ac ChIP analysis of infected NIH-3T3 cells treated with or without TSA. ChIP data is 
presented as % of input DNA as described above. Results shown are means ± SEMs from three 
independent experiments performed in duplicates. Mitochondrial DNA polymerase (negative 
control gene), GAPDH (positive control gene). 
 
FIGURE 6. Characterization of the kinetics of nucleocapsid (NC) and capsid (CA) association 
with viral DNA following reverse transcription 
 
(A) MLV-NC ChIP analysis of chromatin harvested at indicated time points following MLV-
GFP infection of NIH-3T3 cells. ChIP data is presented as % of input DNA as described above. 
Results shown are means ± SDs from two independent experiments performed in duplicates. 
 
(B) Similar experiment as (A) using MLV-CA antibodies for ChIP. 
 
(C) MLV-NC and CA ChIP analysis of chromatin harvested from infected, aphidicolin (Aph) 
treated NIH-3T3 cells. ChIP data is presented as % of input DNA as described above. Results 
shown are means ± SDs from two independent experiments performed in duplicates. 
 



























CHAPTER 6 - DISCUSSION 
The data presented in the previous chapters encompasses various aspects of the retroviral life 
cycle during early phases of infection. In the following section, I will individually discuss the 
implications of our findings and suggest some future investigations. 
 
EBP1, a novel host factor involved in primer binding site-dependent restriction of moloney 
murine leukemia virus in embryonic cells 
I began my graduate work studying the phenomenon of MLV silencing in mouse embryonic cells 
(Chapter 2). The ability of mouse embryonic cells to silence the MLV promoter lies in its 
expression of the sequence specific KRAB-ZFP ZFP809. ZFP809, through its interaction with 
the PBSpro of MLV, serves to coordinate the assembly of macromolecular silencing complexes 
containing TRIM28, ESET, HP1 and others, thereby establishing of a transcriptionally inactive 
provirus. As a continuation of work done by Dr. Daniel Wolf in the lab, we identified a novel 
ZFP809 interacting protein, EBP1, and showed its involvement in facilitating ZFP809/TRIM28 
dependent MLV silencing in mouse embryonic cells. There was no previous history of an 
involvement of EBP1 in ES-cell specific silencing. EBP1 is a known transcriptional repressor of 
E2F1 and androgen receptor regulated promoters (Ghosh et al, 2013; Zhang et al, 2005a; Zhang 
et al, 2002; Zhang et al, 2005b; Zhang et al, 2003) in breast and prostate cancer cell lines. 
Interestingly, our observation of the interaction between EBP1 and TRIM28 coincides with 
previous findings showing the involvement of both proteins at the E2F target promoter (Wang et 
al, 2007). Therefore, it is conceivable that for other cellular promoters, specific DNA binding 
proteins, acting in a manner similar ZFP809, may recruit both EBP1 and TRIM28 to the target 




ubiquitously expressed and could regulate target genes in many cell types, we postulate that cell 
specific promoter regulation will be determined by cell specific zinc finger proteins, which in the 
case of embryonic cells, is ZFP809.  
Of note, EBP1 has been implicated in the biology of RNA viruses in other settings. 
Honda et al identified EBP1 as a novel binding partner for the PB1 subunit of influenza virus 
RNA polymerase and showed that overexpression of EBP1 blocked the transcription of influenza 
virus and led to reduced viral titers (Honda et al, 2007). In another study, it was reported that 
infection of Vero cells by rinderpest virus led to the downregulation of EBP1 expression, and 
that overexpression of EBP1 led to the inhibition of rinderpest virus transcription (Gopinath et al, 
2010). EBP1’s role in antagonizing retroviral infection in embryonic cells expands the repertoire 
of RNA viruses sensitive to EBP1 regulation. Preliminary tests suggest that cellular EBP1 
expression is not altered by retroviral infection (data not shown), and that the course of viral 
DNA synthesis by reverse transcriptase was not affected. 
Mouse embryonic cells suppress the expression of both incoming exogenous retroviruses 
as well as endogenous retroelements.  The loss of either ZFP809 (Wolf et al, 2015), TRIM28 
(Rowe et al, 2010) or SETDB1 (Matsui et al, 2010) in mouse ES cells led to robust activation of 
endogenous retroviruses, as well as failure to block new retroviral infections. In F9 EC cells, 
depletion of EBP1 did not result in the upregulation of various endogenous retroelements (data 
not shown). Therefore, we suggest that although EBP1 is required for the silencing of newly 
integrated provirus, it may be dispensable for the silencing of endogenous retroviral elements. 
Such division of labor has also been observed in the case of the histone methyltransferase G9a 




In summary, our study revealed EBP1 to be a novel component of the PBS-dependent 
silencing machinery in mouse embryonic cells. It should be noted that retroviral silencing is 
mediated through both PBS-dependent, as well as PBS-independent pathways involving the host 
transcription factor Yin Yang 1 (Schlesinger et al, 2013), and further studies will be necessary to 
address the potential crosstalk between these two arms. It will also be of interest to determine 
whether TRIM28 in concert with other KRAB-ZFPs also requires EBP1 to mediate silencing in 





Regulation of Yin Yang 1 by Tyrosine Phosphorylation 
As an extension of YY1’s role in MLV silencing, I became interested in understanding 
how YY1 activity is regulated through post-translational modifications. In chapter 3, I showed 
that YY1 is a target of tyrosine phosphorylation across many cell types. Using a combination of 
kinase inhibitors, kinase overexpression and kinase knockout studies, we arrived at the 
conclusion that YY1 phosphorylation is likely mediated by multiple Src family kinases. The nine 
Src family kinases exhibit different tissue expression patterns. For example, c-Src, Fyn, and Yes 
are ubiquitously expressed (Stein et al, 1994), while Lyn shows preferential expression in 
hematopoietic cells (Hibbs et al, 1995). Given the conservation of YY1 phosphorylation across 
different cell types, we postulate that depending on the Src kinase signature within a cell, 
different cell types may utilize different members of the kinase family for phosphorylating YY1. 
Thus, this mechanism of YY1 regulation may be functioning in a wide range of tissues and 
settings.    
In Lyn-overexpressing cells, overall YY1 phosphorylation was greatly reduced by single 
mutations at either tyrosine 8, 254 or 383, suggesting that these three sites are preferentially 
phosphorylated by Lyn, and that phosphorylation of these sites may occur in a cooperative 
manner, since mutations at each site greatly reduced the likelihood that the other sites become 
phosphorylated in vivo. Phosphorylation of bacterially purified Y383F YY1 using recombinant 
Lyn was also significantly reduced in vitro. However, in both Src and Yes overexpressing cells, 
YY1 was preferentially phosphorylated on different residues, suggesting that the sites of YY1 
phosphorylation in a given cell type may depend on the expression pattern of Src family kinases 




To examine the functional importance of YY1 phosphorylation sites uncovered by our 
mutagenesis analysis, we tested the effect of introducing phosphomimetic and 
nonphosphorylatable mutations on the ability of YY1 to regulate gene expression driven by both 
retroviral and cellular promoters. Our observation that overexpression of Y383E, but not Y383F, 
affected the ability of YY1 to either transactivate the HTLV-1 promoter, or repress the MLV or 
endogenous c-fos promoter highlighted the functional importance of this tyrosine residue.  
YY1 contains four C2H2 zinc finger domains, each of which is comprised of conserved 
cysteines, histidines and hydrophobic residues folding to form a  structure surrounding a 
central zinc ion (Houbaviy et al, 1996). Y383 is located at the very start of the fourth zinc finger, 
before the first cysteine of the CCHH cluster chelating the zinc, and is not the highly conserved 
bulky hydrophobic residue in the center of the zinc finger. A closer inspection of the co-crystal 
structure of YY1 bound to the AAV P5 promoter initiator element (Houbaviy et al, 1996) reveals 
that tyrosine 383, together with valine 384 and critical cysteine 385 participate in the formation 
of the first -sheet of the fourth zinc finger. Hence, one would predict that the addition of a 
phosphate at this position may perturb the first -sheet, thus interfering with zinc and/or nucleic 
acid binding. We cannot rule out the possibility that phosphorylation induced changes in protein 
folding may also affect YY1’s affinity for other transcriptional cofactors such as CTCF 
(Donohoe et al, 2007) and Smads (Kurisaki et al, 2003). 
The importance of Y383 is supported by biochemical assays showing reduced DNA and 
RNA binding by the Y383E mutant. Apart from tyrosine 383, it is surprising that 
phosphomimetic mutations at the other five tyrosines failed to affect YY1 function in the context 
of HTLV-1 transactivation. For example, tyrosine 185 lies in close proximity to serine 180 and 




binding and YY1 acetylation (Kassardjian et al, 2012). In spite of this proximity, the Y185E and 
Y185F mutants maintained full transactivation activity on the HTLV-1 promoter. Therefore, the 
simplest explanation is that phosphorylation of the other five tyrosines is not important for 
YY1’s activation function.  
Inactivation of gene-specific transcription factors often affects control of cell division and 
mitosis. One mechanism of transcription factor inactivation during the cell cycle involves 
serine/threonine phosphorylation of the consensus TGEKP zinc finger linker sequence in C2H2 
transcription factors such as Sp1, Ikaros (Dovat et al, 2002) and YY1 (Rizkallah et al, 2011a; 
Rizkallah & Hurt, 2009), leading to reduced DNA binding., YY1 activity may also be similarly 
controlled during the cell cycle by phosphorylation of tyrosine 383. To our knowledge, 
regulation of a C2H2 transcription factor through tyrosine phosphorylation of its zinc finger has 
not been documented. In YY1, tyrosine 383 makes up part of the consensus Y-X-C motif that is 
also found at the start of many other C2H2 transcription factors (Brayer & Segal, 2008), thereby 
raising that possibility that other C2H2 family members may be regulated in a similar manner.  
YY1 is a stable, constitutive and widely expressed protein across many cell types (Austen 
et al, 1997). This makes regulation of YY1 through post-translational modifications an attractive 
mean of controlling its activity. The levels of tyrosine phosphorylated YY1 is low under basal 
conditions, but becomes readily detectable upon the inhibition of endogenous tyrosine 
phosphatases or the activation of cytosolic tyrosine kinases via EGFR signaling. Given that 
protein phosphorylation is dictated by the balance between kinase and phosphatase activities, our 
data suggests that the majority of YY1 is unphosphorylated and available for DNA binding under 
steady-state conditions, leading to persistent activation or repression of YY1 responsive genes. 




DNA binding capacity of YY1 through tyrosine phosphorylation, thereby permitting temporal 
fine-tuning of YY1-responsive promoters.   
Under steady-state conditions, YY1 is predominantly a nuclear protein with a minor 
cytoplasmic presence (Austen et al, 1997). Cellular fractionation experiments using pervanadate-
treated Jurkat cells showed high levels of tyrosine phosphorylated YY1 in the nucleus and trace 
amounts in the cytoplasm. This is consistent with emerging evidence showing that beside 
cytoplasmic localization, a fraction of the Lyn (Radha et al, 1996), Src, Fyn, and Yes kinases 
(Takahashi et al, 2009) is present in the nucleus. Nevertheless, the interplay between YY1 
phosphorylation and cellular localization is a topic of future studies.  
In summary, our work has revealed a novel means of regulating YY1 function through 
tyrosine phosphorylation. Further studies will be necessary to address the specific tyrosine 
phosphatase(s) responsible for YY1 dephosphorylation, as well as the localization and dynamics 
of tyrosine phosphorylated YY1 in vivo. These studies will provide us with a better 







Postentry restriction of Mason-Pfizer monkey virus in mouse cells 
My next project revolved around an interesting observation that mouse cells are resistant 
to infection by M-PMV, a prototypical simian betaretrovirus. As shown in chapter 4, the block is 
very potent (50-100 fold) and resistance to M-PMV appears to be widespread among many cell 
types. Moreover, the observation that mouse cells blocked M-PMV reporter viruses pseudotyped 
with various envelope proteins suggests that the block occurs post-entry. Moreover, the process 
of reverse transcription, as measured by the levels of minus-strand strong-stop DNA and the 
reporter GFP DNA, occurred normally in all the mouse cell lines tested. The levels of 2-LTR 
circles, however, were drastically reduced, suggesting a significant block at the time of nuclear 
entry. This conclusion is further supported by diminished levels of integrated proviral DNA 
remaining in mouse cells after long-term passage. It is not known if infection of permissive cells 
by M-PMV requires cell division as is the case for MLVs, but the cells used in all our 
experiments were dividing, ensuring that this is not the basis for the block. Given that the defect 
in viral circular DNA formation partially coincides with the timing of Fv1 restriction, we 
hypothesized that the Fv1 alleles present in the various mouse lines might account for the block 




 alleles in human cells failed to 
induce any resistance to M-PMV. This observation was consistent with the inability of M-PMV 
to transduce mouse cells harboring different Fv1 alleles, making Fv1 an unlikely candidate for 
M-PMV restriction. Interestingly, it has been reported that Fv1 also failed to block primate 
lentiviruses (Hatziioannou et al, 2004). Of note, although our data suggest a major defect at the 
approximate time of nuclear entry, we cannot exclude the possibility that additional blocks at the 




The inability of M-PMV to replicate in mouse cells may be due to either the absence or 
incompatibility of critical host factors, or to the presence of active viral restriction factors 
exemplified by Fv1. Infection of heterokaryons formed by the fusion between permissive and 
non-permissive cells can be used to distinguish between the two possibilities. In preliminary tests, 
we found that heterokaryons formed by the fusion of HeLa and NIH-3T3 cells remained resistant 
to M-PMV infection (data not shown), implying that mouse cells may contain a novel dominant 
restriction factor with Fv1-like activity. We cannot rule out the possibility, however, that the 
fusion process itself is causing virus resistance and that the heterokaryons are resistant for other 
reasons. Recently, the effects of human and mouse TRIM proteins on the early and late events of 
HIV and MLV life cycle identified numerous family members with antiviral activities (Uchil et 
al, 2008). With that in mind, it is possible that a ubiquitously expressed mouse-specific TRIM 
protein is responsible for the M-PMV resistance. Preliminary tests of a panel of mouse TRIMs 
expressed in HeLa cells did not reveal any TRIM capable of blocking M-PMV. Identification of 
the putative dominant mouse restriction factor, if present, remains a subject for future 
investigations. Finally, although mouse cells are non-permissive to M-PMV transduction, we 
note that they are susceptible to infection by other betaretroviruses such as mouse mammary 
tumor virus (MMTV). It remains to be determined whether this is due to MMTV’s ability to 






Histones are rapidly loaded onto unintegrated retroviral DNAs soon after nuclear entry 
Finally, the last project examines the question of what is the “state” of the viral DNAs 
following infection. Given that reverse transcription generates de novo foreign DNAs in the host 
cell, this raises the question of what is the histone state of these retroviral DNAs following 
infection. Are retroviral DNAs a target of histone loading? If so, when, where and on what forms 
of viral DNA does this occur? Following reverse transcription, do retroviral DNAs remain 
associated with their cognate structural proteins such as NC and CA? When and where does NC 
and CA dissociate from the viral DNA? Finally, given that unintegrated viral DNAs contribute 
very little to viral gene expression in the infected cell, why is this so?     
By performing histone H3 ChIP analysis on murine cells infected with MLV, we show 
that core histone H3 rapidly associates with total viral DNAs following infection. Moreover, 
experiments using either integrase mutant MLV or raltegravir treated cells demonstrate that 
histone loading of total viral DNAs occurs independently of viral integration. Total viral DNA is 
composed of linear DNA, a direct product of reverse transcription and a substrate for integration, 
circular DNA, a marker of nuclear entry, and fully integrated proviral DNA. 2-LTR circles 
constitute 10-15% of total viral DNAs, while the remaining is made up of mostly linear DNA, 
other forms of circular DNA, and fully integrated proviral DNA. From this, we deduce that 
during early infection, histone loading of linear DNA must account for a fraction of the total 
ChIP signal. Since linear DNA also serve as precursors to 2-LTR circles, one can envision 
several potential mechanisms of histone loading onto 2-LTR circles, including (1) histone 
loading onto linear DNA followed by circularization, (2) circularization followed by histone 
loading, or (3) histone loading and DNA circularization occurring simultaneously. Our current 




The majority, if not all of the histone loading onto viral DNAs occurs in the nucleus. This 
is supported by our observation that perturbation of viral nuclear entry, either by infecting 
aphidicolin arrested cells with MLV, or by infecting mouse cells with M-PMV, a virus 
previously shown to be defective in nuclear entry, all caused a marked reduction in the extent of 
histone H3 association with total viral DNAs.   
Using a previously characterized model of MLV promoter silencing in mouse embryonic 
cells, we were able to directly measure the timing of epigenetically modified histone association 
with viral DNAs. In F9 embryonic carcinoma cells, significant core histone loading occurred as 
early as 12 h post infection. In contrast, modified histone loading, as measured by the presence 
of H3K9 trimethylation (H3K9me3), became evident much later at 6 days post infection. The 
delay in the appearance of modified histones on the viral DNAs correlates with the delay in the 
complete transcriptional silencing of the MLV promoter. In the case of differentiated cells, 
where the MLV promoter is fully active, acetylated histone H3 loading was also found to occur 
much later at 6 days compared to core histone loading as early as 12 h. Together, these data 
suggest that the appearance of both repressive and active histone marks occur after core histone 
loading, thereby causing a transient delay in the host cell modulation of viral gene expression. In 
host cells, DNA replication during S-phase is associated with rapid reassembly of nucleosomes 
and inheritance of parental histone modifications (Zentner & Henikoff, 2013). This is achieved 
by histones around the parental DNA strand acting as a template to direct histone modifications 
of the daughter DNA strand (Zhu & Reinberg, 2011). Retroviral infection generates de novo 
foreign DNA that the cell has never seen before, hence the delay in the appearance of histone 
marks may reflect the absence of previously established epigenetic memory, and the timing 




Using a catalytically inactive IN mutant (D184A), we were able to study gene expression 
derived from unintegrated viral DNAs. Under basal conditions, the expression level from 
unintegrated viral DNAs was very low compared to integrated proviral DNAs, consistent with 
previous reports (Nakajima et al, 2001; Poon & Chen, 2003). However, the addition of HDAC 
inhibitor TSA following infection caused a marked increase in the expression of unintegrated, 
but not integrated viral DNAs. The increase in expression from unintegrated DNAs appears to be 
a product of two mechanisms. First, the increase in gene expression from unintegrated viral DNA 
was accompanied by an increase in the association of acetylated histone H3, a marker of actively 
transcribed genes, with the viral promoter, thus favoring the recruitment of the host 
transcriptional machinery. Interestingly, such H3Ac enrichment was only observed on total viral 
DNA, but not 2-LTR circles, implying that the enhanced gene expression may be a product of 
increased transcription from only linear DNA templates and not circular forms. Secondly, TSA 
appears to increase the stability of unintegrated, but not integrated DNA forms, thereby 
increasing the amount of viral template available for transcription. Why this is the case is a topic 
for future investigations, one possibility is that TSA treatment may prolong the half-life of 
unintegrated DNA forms by reducing the activity of the DNA degradation machinery in the 
nucleus. 
Using antibodies specific for the NC and CA proteins of MLV, we were able to follow 
the kinetics of NC and CA dissociation from the viral DNA following infection. High degree of 
NC and CA association with the viral DNA early during infection followed by rapid decay 
coincides with the timing of histone loading, suggesting that the two events may be mutually 
exclusive. Indeed, by blocking nuclear entry and preventing histone loading, we were able to 




entry of viral DNAs into the nucleus, core histones may compete with NC and CA for binding to 
the viral DNAs, leading to their disassembly.  
The precise mechanism by which core histones are loaded onto retroviral DNAs remains 
a mystery, and likely requires the activity of cellular histone chaperones. Since retroviral 
infection generates newly synthesized DNA through reverse transcription, one may predict that 
histone loading of viral DNA is analogous to histone loading of newly synthesized cellular DNA 
during DNA replication. For cellular DNA, the Caf1 complex is thought to mediated de novo 
histone H3/H4 assembly of newly synthesized DNA during replication (Gaillard et al, 1996; 
Kaufman et al, 1995). However, preliminary experiments using Caf1 knockdown cells showed 
no impairment in the extent of histone loading onto viral DNAs (data not shown), highlighting 
the likely involvement of other chaperones, a topic of future studies. Equally interesting is the 
question of whether viral encoded proteins play a role in facilitating histone loading onto its own 
DNA. 
Future studies will be aimed at elucidating the effect of histone loading on the retroviral 
replication potential. For instance, does histone loading protects linear DNA from degradation? 
Does histone loading of linear DNA promote efficient integration or integration site selection? 
Answering these questions will require an understanding of the cellular machinery responsible 
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